Literature DB >> 25081912

Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.

Liusong Yin1, Lawrence J Stern1,2.   

Abstract

Peptide binding to major histocompatibility complex class II (MHCII) molecules is a key process in antigen presentation and CD4+ T cell epitope selection. This unit describes a fairly simple but powerful fluorescence polarization-based binding competition assay to measure peptide binding to soluble recombinant MHCII molecules. The binding of a peptide of interest to MHCII molecules is assessed based on its ability to inhibit the binding of a fluorescence-labeled probe peptide, with the strength of binding characterized as IC50 (concentration required for 50% inhibition of probe peptide binding). Data analysis related to this method is discussed. In addition, this unit includes a support protocol for fluorescence labeling peptide using an amine-reactive probe. The advantage of this protocol is that it allows simple, fast, and high-throughput measurements of binding for a large set of peptides to MHCII molecules.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  IC50; MHCII; binding competition; fluorescence polarization; peptide binding

Mesh:

Substances:

Year:  2014        PMID: 25081912      PMCID: PMC4151172          DOI: 10.1002/0471142735.im0510s106

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  40 in total

1.  Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.

Authors:  Andrea Ferrante; Jack Gorski
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

2.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

3.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

4.  Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis.

Authors:  Taejin Yoon; Henriette Macmillan; Sarah E Mortimer; Wei Jiang; Cornelia H Rinderknecht; Lawrence J Stern; Elizabeth D Mellins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

5.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

6.  Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.

Authors:  Zemin Zhou; Kari A Callaway; Dominique A Weber; Peter E Jensen
Journal:  J Immunol       Date:  2009-10-01       Impact factor: 5.422

7.  Kinetics and specificity of peptide-MHC class II complex displacement reactions.

Authors:  A I de Kroon; H M McConnell
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

8.  In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange.

Authors:  Melissa J Call; Xuechao Xing; Gregory D Cuny; Nilufer P Seth; Daniel M Altmann; Lars Fugger; Michelle Krogsgaard; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.

Authors:  Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig
Journal:  Nat Immunol       Date:  2010-12-05       Impact factor: 25.606

10.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

View more
  15 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

2.  The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.

Authors:  Yi Tian Ting; Jan Petersen; Sri H Ramarathinam; Stephen W Scally; Khai L Loh; Ranjeny Thomas; Anish Suri; Daniel G Baker; Anthony W Purcell; Hugh H Reid; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

3.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

4.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

5.  Rapid microsphere-assisted peptide screening (MAPS) of promiscuous MHCII-binding peptides in Zika virus envelope protein.

Authors:  Mason R Smith; Luke F Bugada; Fei Wen
Journal:  AIChE J       Date:  2019-06-11       Impact factor: 3.993

6.  A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding.

Authors:  Brooke D Huisman; Zheng Dai; David K Gifford; Michael E Birnbaum
Journal:  Elife       Date:  2022-07-04       Impact factor: 8.713

7.  Desmoglein 3 Order and Dynamics in Desmosomes Determined by Fluorescence Polarization Microscopy.

Authors:  Emily I Bartle; Tara M Urner; Siddharth S Raju; Alexa L Mattheyses
Journal:  Biophys J       Date:  2017-12-05       Impact factor: 4.033

Review 8.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

9.  Autoimmune response to transthyretin in juvenile idiopathic arthritis.

Authors:  Cristina C Clement; Halima Moncrieffe; Aditi Lele; Ginger Janow; Aniuska Becerra; Francesco Bauli; Fawzy A Saad; Giorgio Perino; Cristina Montagna; Neil Cobelli; John Hardin; Lawrence J Stern; Norman Ilowite; Steven A Porcelli; Laura Santambrogio
Journal:  JCI Insight       Date:  2016-02-25

10.  Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery.

Authors:  Cristina C Clement; Padma P Nanaware; Takahiro Yamazaki; Maria Pia Negroni; Karthik Ramesh; Kateryna Morozova; Sangeetha Thangaswamy; Austin Graves; Hei Jung Kim; Tsai Wanxia Li; Marco Vigano'; Rajesh K Soni; Massimo Gadina; Harley Y Tse; Lorenzo Galluzzi; Paul A Roche; Lisa K Denzin; Lawrence J Stern; Laura Santambrogio
Journal:  Immunity       Date:  2021-03-15       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.